13F-HR filed by DEERFIELD MANAGEMENT COMPANY, L.P.
DEERFIELD MANAGEMENT COMPANY, L.P. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:05:11 UTC, with 77 holding rows worth $6,465,822,053.
- Accession
- 0001213900-26-120609
- Filer
- CIK 1009258
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
13F report for Q3 2026
A holdings report, 77 entries on the cover page, a total value of $6,465,822,053 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,465,822,053 with VALUE read as dollars as filed, 13F file number 028-05366. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerDeerfield UGP, LLC 028-25875
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| REVOLUTION MEDICINES INC COM | 76155X100 | Stock | 2,124,000 | $435,972,240 | dollars as filed | |
| BROOKDALE SR LIVING INC | 112463AF1 | NOTE 3.500%10/1 | 306,885,000 | $425,592,108 | dollars as filed | principal |
| CENTENE CORP DEL COM | 15135B101 | Stock | 4,901,000 | $304,450,120 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 540,598 | $292,944,650 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 963,351 | $280,556,712 | dollars as filed | |
| REVOLUTION MEDICINES INC | 76155XAA8 | NOTE 0.500% 5/0 | 200,000,000 | $257,828,400 | dollars as filed | principal |
| GENMAB A/S | 372303206 | Ordinary Shares, nominal value DKK 1 per share | 6,865,000 | $244,908,875 | dollars as filed | |
| Arrowhead Pharmaceuticals In Note 1/1 | 04280AAC4 | Convertible | 200,000,000 | $205,521,800 | dollars as filed | principal |
| VIATRIS INC COM | 92556V106 | Stock | 10,938,000 | $193,821,360 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 5,957,000 | $190,743,140 | dollars as filed | |
| CELCUITY INC | 15102K100 | COM | 2,397,664 | $190,662,241 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 8,137,638 | $161,857,620 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 4,338,778 | $140,099,142 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 5,180,000 | $129,241,000 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 15,490,928 | $129,039,430 | dollars as filed | |
| BROOKDALE SR LIVING INC | 112463104 | COM | 11,637,032 | $126,029,057 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 2,025,146 | $121,508,760 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 2,660,669 | $118,798,871 | dollars as filed | |
| LARIMAR THERAPEUTICS INC | 517125100 | COM | 35,606,974 | $113,764,282 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 4,254,314 | $103,464,916 | dollars as filed | |
| MINERALYS THERAPEUTICS INC | 603170101 | COM | 3,958,000 | $99,464,540 | dollars as filed | |
| Celcuity Inc Note 0.250 percent 8/0 | 15102KAB6 | Convertible | 100,000,000 | $96,476,400 | dollars as filed | principal |
| Boston Scientific Corporation | 101137107 | COM | 2,135,440 | $93,211,956 | dollars as filed | |
| CHEMED CORP NEW | 16359R103 | COM | 182,000 | $91,922,740 | dollars as filed | |
| INSPIRE MED SYS INC COM | 457730109 | Stock | 1,296,862 | $89,950,348 | dollars as filed | |
| TEMPUS AI INC | 88023BAE3 | NOTE 0.750% 7/1 | 70,000,000 | $88,163,600 | dollars as filed | principal |
| ZENAS BIOPHARMA INC | 98937LAA3 | NOTE 2.500% 4/0 | 67,200,000 | $85,735,507 | dollars as filed | principal |
| BIO RAD LABS INC | 090572207 | CL A | 226,070 | $85,388,900 | dollars as filed | |
| PHARVARIS NV | N69605108 | COMMON STOCK | 2,590,000 | $82,154,800 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 914,000 | $80,477,700 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 2,003,000 | $76,955,260 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 3,779,900 | $71,062,120 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 13,569,000 | $70,016,040 | dollars as filed | |
| CERTARA INC COM | 15687V109 | Stock | 7,512,928 | $69,118,938 | dollars as filed | |
| ACADIA HEALTHCARE COMPANY INC COM | 00404A109 | Stock | 2,493,589 | $68,573,698 | dollars as filed | |
| IONIS PHARMACEUTICALS INC | 462222AF7 | NOTE 1.750% 6/1 | 60,000,000 | $65,965,500 | dollars as filed | principal |
| ADAPTHEALTH CORP | 00653Q102 | COMMON STOCK | 11,477,730 | $64,734,397 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC | 01625VAB0 | NOTE 4.250%11/1 | 61,000,000 | $61,114,741 | dollars as filed | principal |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 1,880,704 | $60,727,932 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 1,615,696 | $60,087,734 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 843,063 | $55,178,473 | dollars as filed | |
| ENVISTA HOLDINGS CORPORATION | 29415F104 | COM | 2,210,100 | $51,871,047 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 1,823,500 | $47,411,000 | dollars as filed | |
| ZOETIS INC CL A | 98978V103 | Stock | 632,000 | $44,132,560 | dollars as filed | |
| LIVANOVA PLC | 53802LAB8 | NOTE 2.500% 3/1 | 34,280,000 | $43,971,950 | dollars as filed | principal |
| DISC MEDICINE INC COM | 254604101 | Stock | 657,000 | $43,007,220 | dollars as filed | |
| BETA BIONICS INC | 08659B102 | COMMON STOCK | 1,903,710 | $36,132,416 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 1,086,000 | $33,959,220 | dollars as filed | |
| ARS PHARMACEUTICALS INC | 82835W108 | COM | 7,503,812 | $32,341,430 | dollars as filed | |
| BELITE BIO INC | 07782B104 | CMN | 190,000 | $32,265,800 | dollars as filed | |
| COOPER COS INC | 216648501 | COM | 557,000 | $31,487,210 | dollars as filed | |
| BLOSSOMHILL THERAPEUTICS INC | 095130100 | COM | 1,446,000 | $26,953,440 | dollars as filed | |
| Odyssey Therapeutics, Inc. | 67613T104 | COMMON STOCK | 1,046,139 | $23,245,209 | dollars as filed | |
| TANDEM DIABETES CARE INC | 875372203 | COM NEW | 1,390,909 | $22,685,726 | dollars as filed | |
| STARLING ONCOLOGY INC | 68236X100 | COMMON STOCK | 3,360,052 | $21,235,529 | dollars as filed | |
| AVALYN PHARMA INC | 05348Y105 | COMMON STOCK | 731,000 | $20,826,190 | dollars as filed | |
| ALAMAR BIOSCIENCES INC | 010911105 | COMMON STOCK | 600,000 | $20,442,000 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 732,392 | $16,017,413 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 4,394,367 | $15,687,890 | dollars as filed | |
| VOGENX INC | 92859A106 | COM | 635,707 | $14,487,763 | dollars as filed | |
| EMBECTA CORP | 29082K105 | COMMON STOCK | 2,534,961 | $14,347,879 | dollars as filed | |
| BRIDGEBIO ONCOLOGY THERAPEUT | 107924102 | COM NEW | 3,138,167 | $12,866,485 | dollars as filed | |
| NEOGENOMICS INC | 64049MAB6 | NOTE 0.250% 1/1 | 13,040,000 | $12,250,937 | dollars as filed | principal |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 236,295 | $11,772,217 | dollars as filed | |
| MONOPAR THERAPEUTICS INC | 61023L207 | COMMON STOCK | 137,591 | $10,961,875 | dollars as filed | |
| ALIGNMENT HEALTHCARE INC COM | 01625V104 | Stock | 1,172,418 | $9,566,931 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 2,666,666 | $8,533,331 | dollars as filed | |
| HEMAB THERAPEUTICS HLDGS INC | 423494103 | COM SHS | 275,000 | $8,481,000 | dollars as filed | |
| Electra Therapeutics, Inc. | 284825106 | Common Stock, $0.0001 par value per share | 700,000 | $7,875,000 | dollars as filed | |
| ANNEXON INC | 03589W102 | COM | 583,913 | $2,469,952 | dollars as filed | |
| ALECTOR INC | 014442107 | COMMON STOCK | 1,055,192 | $1,952,105 | dollars as filed | |
| EDWARDS LIFESCIENCES CORP COM | 28176E108 | Stock | 13,702 | $1,182,757 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 92,787 | $1,173,756 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 6,027 | $515,188 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 917 | $349,900 | dollars as filed | |
| The Oncology Institute Inc W Exp 99/99/999 | 68236X118 | SPAC Combination | 1,250,000 | $61,000 | dollars as filed | |
| PMV PHARMACEUTICALS INC | 69353Y103 | COM | 8,790 | $14,679 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001213900-26-120609 | this filing | 2026-11-16 |